@crabflower3
Active 1 year, 3 months ago
Objective This study aimed to compare the economic evaluation of recombinant human thrombopoietin+rituximab (rhTPO + RTX) vs. RTX as second-line treatment for adult patients with immunologic thrombocytopenic purpura in China. Methods The Markov model was used in our research. The response rate and relapse rate data were derived from two clinical […] View